Security key
753018100
Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI)
CUSIP: 753018100
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Class A Common Stock, $0.0001 par value per share
- Total 13F shares
- 3,609,389
- Total 13F value
- $4,577,211
- Share change
- -210,078
- Put/Call ratio
- 251%
- SEC-reported price per share
- $1.26
- Number of holders
- 38
- Value change
- -$332,797
- Number of buys
- 14
- Number of sells
- 13
- Shares outstanding
- 116,468,828
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
38
Top holders
10
RANI full security history
Ownership snapshot
Full 13F holder table
Rani Therapeutics Holdings, Inc. SEC filings
Rani Therapeutics Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RANI - Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 0.61%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 0.61%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
0.61%
Nan Fung Group Holdings Ltd
0.42%
Alphabet Inc.
0.39%
UNITED SERVICES AUTOMOBILE ASSOCI...
0.26%
TWO SIGMA INVESTMENTS, LP
0.25%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
0.61%
|
$972,465
709,828 shares
|
— | 31 Dec 2024 |
| Nan Fung Group Holdings Ltd |
13F
Company
|
0.42%
|
$676,210
493,584 shares
|
— | 31 Dec 2024 |
| Alphabet Inc. |
13F
Company
|
0.39%
|
$614,434
448,492 shares
|
— | 31 Dec 2024 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION |
13F
Company
|
0.26%
|
$414,758
302,743 shares
|
— | 31 Dec 2024 |
| TWO SIGMA INVESTMENTS, LP |
13F
Company
|
0.25%
|
$399,192
291,381 shares
|
— | 31 Dec 2024 |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
Company
|
0.17%
|
$278,370
203,190 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
3,609,389
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
38
Q1 2025 holders
38
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|